(This show was recorded on 31st July 2025)
Brian and Mik catch up on a few investment ideas they have been following
What we cover
- ANSYS × Synopsys: the deal closed; why a stock-and-cash structure gave us yield and long-term exposure, and how we’re thinking about integration risk and the opportunity ahead. (TLdR: We are still long Synosys)
- Semis & the “foundry question”: Intel sentiment whiplash, a new CEO with a turnaround pedigree, and the reality of competing with TSMC scale. We speculate on Intel's potential outcome(s) and what second-order effects may be for the ecosystem, including TSMC.
- Viking Therapeutics (VKTX): why a fast-follower with both subcutaneous and oral programs still looks interesting in a market dominated by Novo/Lilly; the real risks (short interest, dilution, timelines) and why patience, position sizing and buying well matters.
- Process over predictions: how we use updates like these to revisit assumptions without over-trading the noise.
Disclaimer: The views expressed are for entertainment purposes only. This is not investment advice. Please do your own research before making any financial decisions.
What is FOMO Investing?
Brian and Mik explore the world of investing through real-world examples and behavioral economics principles.